Roivant Sciences vs West Pharmaceutical Services
Roivant Sciences (ROIV), health care, and West Pharmaceutical Services (WST), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
West Pharmaceutical Services is worth $28.8B on the stock market and Roivant Sciences $28B: West Pharmaceutical Services is valued at 3% more. Roivant Sciences's operating margin in its latest fiscal year was -6236% and West Pharmaceutical Services's 19.0%. Over the past year Roivant Sciences's share price has moved +88.2% and West Pharmaceutical Services's +60.6%.
Key facts
- Roivant Sciences market value
- $28B
- West Pharmaceutical Services market value
- $28.8B
- West Pharmaceutical Services P/E
- 46.5
- Roivant Sciences revenue
- $8.3MFY to 2026-03-31
- West Pharmaceutical Services revenue
- $3.1BFY to 2025-12-31
- Superinvestors holding both
- 0
Market values as of .
| Measure | Roivant Sciences | West Pharmaceutical Services |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2026-03-31 | 2025-12-31 |
| Size | ||
| Market cap | $28Blower | $28.8Bhigher |
| Revenue | $8.3Mlower | $3.1Bhigher |
| Earnings | -$299.8Mlower | $493.7Mhigher |
| Employees | 721lower | 10,000higher |
| Total assets | $5.7Bhigher | $4.3Blower |
| Valuation | ||
| P/E | — | 46.5 |
| P/S | 3396higher | 9.4lower |
| P/B | — | 9.7 |
| Dividend yield | — | 0.21% |
| Profitability | ||
| Operating margin | -6236%lower | 19.0%higher |
| Balance sheet | ||
| Net assets | $4.5Bhigher | $3.2Blower |
| Total liabilities | $416.3Mlower | $1.1Bhigher |
| Total debt | — | $202.8M |
| Cash on hand | $1.4Bhigher | $791.3Mlower |
| Price change | ||
| Today | +0.26%higher | -0.88%lower |
| 1 year | +88.2%higher | +60.6%lower |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (0)
None of the tracked investors.
Roivant Sciences only (6)
- Andrew Spokes4.1%
- David Einhorn1.9%
- Lee Ainslie0.9%
- Julian and Felix Baker0.8%
- Andreas Halvorsen0.6%
- Steve Cohen0.2%
West Pharmaceutical Services only (3)
- Bill Gates0.5%
- Brandon Haley0.2%
- Ron Baron0.1%
Percentages are each holding's share of that investor's reported portfolio. Who owns ROIV · Who owns WST
More on Roivant Sciences
More on West Pharmaceutical Services
Further comparisons
Roivant Sciences against its closest peers
West Pharmaceutical Services against its closest peers
Learn
Questions and answers
Which is bigger, Roivant Sciences or West Pharmaceutical Services?
By market value, West Pharmaceutical Services is the larger: $28.8B against $28B for Roivant Sciences. By revenue in its latest fiscal year, West Pharmaceutical Services is the larger: $3.1B against $8.3M for Roivant Sciences.
Which has the higher operating margin?
West Pharmaceutical Services: 19.0%, against -6236% for Roivant Sciences. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which superinvestors own both Roivant Sciences and West Pharmaceutical Services?
None of the tracked superinvestors holds both in their latest 13F filing. 6 hold Roivant Sciences and 3 hold West Pharmaceutical Services.
Cite this page
Funkfolio, “Roivant Sciences vs West Pharmaceutical Services”, data as of 18 November 2026. https://funkfolio.com/compare/roiv-vs-wst
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.